Thus, we proposed that phillyrin hinders PI3K/AKT/mTOR signaling pathway activation, decreases mTOR downstream effector activation, and ultimately inhibits colorectal cancer proliferation and EMT progression. This evidence concerns the gene AKT1 and colorectal cancer.